About the Product

Description


Ondotyle 16 Tablet containing Ondansetron is used for the management of nausea and vomiting associated with various medical conditions and therapeutic procedures. It helps improve patient comfort and supports better treatment compliance.

Ondansetron works as a selective 5-HT3 receptor antagonist that blocks serotonin-mediated signals responsible for triggering nausea and vomiting, thereby providing effective antiemetic action.

The tablet is widely prescribed in gastroenterology, oncology, and general medicine practice for nausea and vomiting associated with gastrointestinal disorders, postoperative conditions, and specific medical treatments, leading to consistent prescription demand.

With increasing demand for effective antiemetic therapies across multiple healthcare specialties, this product offers strong business potential for retailers and distributors. Its established therapeutic efficacy, broad clinical relevance, and steady market demand make it a reliable product for growth in the gastro care segment.

Some patients may experience headache, constipation, diarrhea, dizziness, fatigue, or flushing. Rarely, cardiac rhythm abnormalities, severe allergic reactions, serotonin syndrome, or liver function disturbances may occur and require immediate medical attention.

Ondotyle 16 Tablet is indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, postoperative recovery, gastrointestinal disorders, and other conditions as prescribed by a healthcare professional. It helps improve patient comfort and supports recovery by controlling emesis.

This medicine should be used strictly under medical supervision. Use cautiously in patients with cardiac rhythm disorders, electrolyte imbalances, liver impairment, or those taking other medications that may affect heart rhythm. Follow the prescribed dosage and duration of treatment carefully.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ondansetron 16mg Tablet in the PCD pharma franchise market?

Ondansetron 16mg Tablet has strong demand in the gastroenterology, oncology supportive care, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on gastrointestinal and supportive care portfolios.

Why should medical distributors include Ondansetron 16mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for nausea and vomiting management under medical supervision. Ondansetron 16mg is a selective 5-HT3 receptor antagonist that helps prevent and control nausea and vomiting Commonly prescribed for chemotherapy-induced nausea and vomiting, radiation-induced nausea, postoperative nausea and vomiting, and other conditions associated with severe nausea Helps improve patient comfort and treatment adherence by effectively controlling emesis Widely used in hospitals, oncology centers, surgical settings, and general medical practice This strengthens a comprehensive gastrointestinal and supportive care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ondansetron 16mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand across multiple specialties, repeat orders, reliable supply chain support, broad market acceptance, and attractive margins in the antiemetic segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.